Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Hryz-T101 Tcr-T Cell
Oropharyngeal Carcinoma
HRYZ Biotech Co.
P1
CC
(43)
Hryz-T101 Tcr-T Cell
Vaginal Neoplasm
HRYZ Biotech Co.
P1
CC
(43)
hs-10502
Gastric Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1
CC
(43)
hs-10502
Her2-Receptor Negative Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1
CC
(43)
hs-10504
Non-Small Cell Lung Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1
CC
(43)
hs135
Diastolic Heart Failure
35Pharma Inc
P1
CC
(43)
hs135
Pulmonary Hypertension
35Pharma Inc
P1
CC
(43)
hs-20089
Gastric Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1
CC
(43)
hs-20089
Her2-Receptor Negative Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1
CC
(43)
hs-20093
Gastric Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1
CC
(43)
hs-20093
Her2-Receptor Negative Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1
CC
(43)
hs235
Diastolic Heart Failure
35Pharma Inc
P1
CC
(43)
hs235
Pulmonary Hypertension
35Pharma Inc
P1
CC
(43)
hsk47977
Non-Hodgkin Lymphoma
Haisco Pharmaceutical Group Co., Ltd.
P1
CC
(43)
Hucart19-Il18-Edhfr Cells
Follicular Lymphoma
University of Pennsylvania
P1
CC
(43)
Huc-Msc-Sev-001 Nasal Drops
Frontotemporal Dementia
Xuanwu Hospital, Beijing
P1
CC
(43)
Huc-Msc-Sev-001 Nasal Drops
Lewy Body Dementia
Xuanwu Hospital, Beijing
P1
CC
(43)
Huc-Msc-Sev-001 Nasal Drops
Multiple System Atrophy
Xuanwu Hospital, Beijing
P1
CC
(43)
Human Dopaminergic Progenitor Cells
Young-Onset Parkinson Disease
iRegene Therapeutics Co., Ltd.
P1
CC
(43)
Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors
Parkinson Disease
University of California, San Diego
P1
CC
(43)
Humanized Immunoglobulin G1-Kappa Anti-(Human Cd8) Fused At The C-Terminus Of One Heavy Chain, Via Peptide Linker <Sup>449</Sup> Sggggsggggsggggs<Sup>464</Sup>, To A Variant Of Human Interleukin-2, Glycoform Alfa
Small Cell Lung Carcinoma
Amgen
P1
CC
(43)
Human Single Chain Il-12 Mrna-Multiple Dose
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1
CC
(43)
Hwk-007
Non-Small Cell Lung Carcinoma
Whitehawk Therapeutics, Inc.
P1
CC
(43)
Hwk-007
Hereditary Thrombophilia Due To Congenital Protein C Deficiency
Whitehawk Therapeutics, Inc.
P1
CC
(43)
Hwk-016, Mucin-16-Targeted Adc
Ovarian Cancer
Whitehawk Therapeutics, Inc.
P1
CC
(43)
Showing 2326 to 2350 of 9,928 assets
Previous
Page 94 of 398
Next
